MSB 13.0% $1.31 mesoblast limited

MSB - Must Sell Bullshit, page-20

  1. 405 Posts.
    lightbulb Created with Sketch. 39
    Biotech stocks are speculative as they have to prove their merit with evidence based trial results. Its like 50:50 chance of positive vs negative trial result.
    MSB Science is great but what use is a product if it doesn't get approved by regulatory authorities for use in mainstream medicine.
    My opinion would be not to sell today... as there are some other trial results awaited.
    I am in healthcare and incurred a financial loss too. there are better biotech stocks which are less risk averse... But i have lost trust in MSB a bit, the swings are just too much

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.31
Change
0.150(13.0%)
Mkt cap ! $1.490B
Open High Low Value Volume
$1.15 $1.33 $1.15 $25.26M 19.99M

Buyers (Bids)

No. Vol. Price($)
7 161000 $1.30
 

Sellers (Offers)

Price($) Vol. No.
$1.31 50400 2
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.